Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Preservative Stabilizes Residual White Cells in Leuko-Reduced Samples

By LabMedica International staff writers
Posted on 20 May 2009
A preservative specifically stabilizes residual white blood cells (rWBCs) in leuko-reduced red blood cell samples.

Compatible with commercially available kits, Leuko Preserve is intended for detection and enumeration of rWBCs by flow cytometric analysis. More...
Flow cytometric enumeration of rWBCs in leuko-reduced blood components must be implemented within 48 hours. Occasionally, problems occur making this difficult.

Streck's (Omaha, NE, USA) Leuko Preserve stabilizes rWBCs for up to seven days following leuko-reduction, extending the timeframe for enumeration. This reduces concerns of sample backlogs, instrument problems, and shipping delays.

Additional Streck cell stabilization products include Streck Cell Preservative for the preservation of bone marrow and tissue samples; Cyto-Chex BCT (Blood Collection Tube) for the preservation of whole blood samples for immunophenotyping by flow cytometry; and Cell-Free DNA BCT, a new blood collection tube for the preservation of cell-free plasma DNA. Cell-Free DNA BCT is for research use only.

Streck has also increased the stability of its three-part Para Check whole blood hematology control. Manufactured specifically for the Sysmex KX-21, pocH-100i, and the SweLab AC920EO, the three-part control now offers closed-vial stability of 132 days. The extended closed-vial stability will allow customers to maintain a quarterly ordering schedule, decreasing shipping costs and increasing the ILQC (interlaboratory quality control) peer groups for each instrument on the assay. Para Check is available in a 2.5-ml or 3.5-ml vial with a pierceable cap to accommodate both open- and closed-mode systems.

STATS, a free interlaboratory quality control program, is offered to all Para Check customers. STATS produces relevant peer group comparison reports and graphs with a quick turnaround time. Data can be submitted by mail, fax or e-mail. The reports include customer data, peer group averages, and computer-generated Levey-Jennings graphs.

Streck is an independent developer and manufacturer of controls for the clinical laboratory.

Related Links:

Streck



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Chromogenic Culture System
InTray™ COLOREX™ ECC
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.